A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
Saved in:
| Title: | A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer. |
|---|---|
| Authors: | Yan M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Yuan P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Ouyang Q; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China., Cheng Y; Department of Oncology, Cancer Hospital of Jilin Province, Changchun, China., Han G; Department of Breast Surgery, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, China., Wang D; Department of Thoracic Surgery, Hainan General Hospital, Haikou, China., Ran L; Department of Oncology, The Affiliated Hospital of Guizhou Medical University/Guizhou Cancer Hospital, Guiyang, China., Sun T; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China., Zhao D; Department of Internal Medicine-Oncology, The First Hospital of Lanzhou University, Lanzhou, China., Bai Y; Department of Oncology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China., Yang S; Department of Breast Cancer and Lymphoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China., Wang X; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital and Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China., Wu R; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China., Zeng X; Breast Center, Chongqing Cancer Hospital, Chongqing University, Chongqing, China., Yao H; Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Ji X; Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China., Jiang J; Department of Surgical Oncology, General Hospital of Mining Industry Group Fuxin, Fuxin, China., Hu X; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Lin H; Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China., Zheng L; Department of Breast-Thoracic Tumor Surgery, Affiliated Hospital of Hainan Medical University, Haikou, China., Zhu Z; Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., Ge W; Center of Oncology, Renmin Hospital of Wuhan University, Wuhan, China., Yang J; Department of Medical Oncology, People's Liberation Army General Hospital, Beijing, China., Cui T; Department of Oncology, Fujian Provincial Hospital, Fuzhou, China., Zhang X; Department of Radiotherapy and Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Lu F; Department of Oncology, The Second Affiliated Hospital of Guiyang Medical University, Guiyang, China., Li W; Department of Radiotherapy, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical College, Kunming, China., Xu H; Department of Oncology, Jilin Second People's Hospital, Jilin, China., Kang M; Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, Guilin, China., Gong P; Department of Oncology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China., Zou L; Department of Oncology, West China Hospital, Sichuan University, Chengdu, China., Liu J; Department of Oncology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China., Zhang H; Department of Oncology, Xinjiang Uygur Autonomous Region Chinese Medicine Hospital, Urumqi, China., Yu H; School of Public Health, Nanjing Medical University, Nanjing, China., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, No.17 Panjiayuannanli, Chaoyang District, Beijing 100021, China. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Oct 24; Vol. 14, pp. 17588359221122715. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359221122715 |
